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Abstract. Microtubules are ubiquitous cellular structures found in eukaryotic organisms and 
responsible for a variety of functions. These functions include mitosis, motility, cytoskeletal 
architecture, intracellular transport and secretion. The major structural component of 
microtubules is tubulin, a dimeric protein molecule consisting of two similar but nonidentical 
subunits (α and β) each of about molecular weight 55,000. With the introduction of radioactive 
colchicine for the first time it has been reported that colchicine binds specifically to tubulin. At 
this point microtubule research stepped up to a new era linking microtubules with other 
spindle poisons which are structurally diverse as well as binding at different sites on to the 
tubulin heterodimer. These antimicrotubular agents have already provided valuable informa- 
tion regarding microtubule-mediated cellular functions and its association and dissociation 
phenomena. Tubulins appear to be conserved proteins based on in vitro copolymerization and 
comigration on polyacrylamide gel electrophoretic properties. Further, amino acid sequences 
of both α and β subunits from a variety of sources also appear to be mostly conserved. The 
evolutionary conservation of tubulin genes is highly reflected at the nucleic acid level as well. 
The estimation of the number of genes for tubulin and their organization in a variety of organisms 
have opened up a new dimension to microtubule and tubulin research. The multigene family 
for tubulins comprising also pseudogenes is suggestive that more than one gene for each α and 
β tubulin is functional in the cell. Therefore, it has been speculated that different tubulin gene 
products contribute to functionally different microtubules at specific stages in cell cycle and cell 
growth. Heterogeneity in both α and β tubulins has already been established during different 
stages of development of the cell. Obviously, it reflects that tubulin genes are highly regulated 
and this regulation might be at the transcriptional and/or translational level. Whatever is the 
actual control mechanism it appears that cells can detect an enhanced pool of depolymerized 
subunits and a rapid and specific control in tubulin gene expression at the transcriptional 
and/or post transcriptional level does occur.
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Introduction 
 
The microtubule system has drawn attention of several workers in the recent past for its 
easy availability from animal brain cells, comparatively easier way of purifying tubulins 
to a homogeneous preparation, its easy polymerization and depolymerization in vitro. 
 
 
Abbreviations used: SDS, sodium dodecyl sulphate; PAGE, Polyacrylamide gel electrophoresis; M r ,
molecular weight; CD, circular dichroism; CHO, Chinese hamster ovary; MBC, methyl benzimidazole-2-yl 
carbamate; CIPC, coumarin and isopropyl-(N-3 chlorophenyl) carbamate; APM, amiprophos-methyl.
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its simple assay by colchicine binding reaction, preparation of cDNA and genome 
analysis. The main thesis of the present review is to answer (i) what is the extent of 
microheterogeneity in tubulins? (ii) how colchicine and its analogues bind with 
tubulin? (iii) what is the mechanism of substoichiometric drug poisoning of micro- 
tubule assembly? (iv) how the biosynthesis of tubulin is regulated? (v) how many 
functional and nonfunctional tubulin genes are present in the cell? (vi) what is the 
genetic complexity of tubulin genes? and (vii) what conservation of tubulin gene 
signifies? 
Several reviews appeared recently on different aspects of tubulin and microtubule 
systems (Biswas et al., 1981; Carlier, 1982; Correia and Williams, 1983; Cowan and 
Dudley, 1983; Hill and Kirschner, 1984) but the informations regarding the questions 
raised above are still fragmentary and emerging. An attempt is being made here to 
discuss the problems enumerated and the documented information.
 
 
Tubulin: A ubiquitous protein 
 
Tubulin is the major constituent of microtubule structure found in all eukaryotic cells. 
Bryan and Wilson (1971) demonstrated that purified tubulin from chick embryo brain 
could be resolved electrophoretically into two closely located components on 8 Μ urea- 
polyacrylamide gels after reduction and acetylation. These two subunits were termed α 
and β tubulins, the β subunit having greater electrophoretic mobility. This separation 
results mainly from a difference of charge, since sodium dodecyl sulphate (SDS)- 
polyacrylamide gel electrophoresis (PAGE) of the two subunits under high ionic 
strength and neutral pH conditions (Weber and Osborn, 1969) shows only a single band 
having an apparent molecular weight Mr around 55,000. However, with SDS-PAGE of 
lower strength and higher pH (Laemmli, 1970), separation of α and β subunits can be 
achieved (Wilson and Bryan, 1974; Linck, 1976). The two subunits were found in 
equimolar quantities in nearly all cells studied (Dustin, 1978) and β tubulin was shown 
to have a Mr of 54,000–58,000 and α tubulin, a Mr of 46,000–54,000 (Feit et al., 1971; 
Olmsted et al., 1971; Raff and Kaumeyer, 1973). These two subunits are distinct, but 
closely related proteins. A close relation between α and β tubulins has been revealed by 
amino acid sequence analysis (Luduena and Woodward, 1975). The 451 amino acid 
residues of α tubulin from pig brain and 445 residues of β tubulin display 41 % sequence 
identity (Postingel et al., 1983). A recent study on several taxonomically distant species 
(Little et al., 1981) demonstrated that the β chain is more conserved than the α chain 
during the course of evolution. Antisera raised against tubulin also cross react across 
species boundaries (Osborne and Weber, 1977). This suggests that the two polypeptides 
have been derived from a common ancestor protein. Each has been highly conserved in 
the course of evolution as indicated by the similarities of tubulins from two widely 
separated species, chick and sea urchin. However, antiserum against β tubulin does not 
react with α tubulin (Piperano and Luck, 1977), indicating that the two subunits are 
distinctly different proteins. Further, they differ also in several biochemical properties. 
For example, β tubulin is phophorylated at a serine residue (Eipper, 1972) and α tubulin 
is tyrosinolated by tubulin tyrosine ligase (Raybin and Flavin, 1977). An enzymatic 
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removal, rather than the addition of tyrosin residue to α tubulin has also been reported 
recently (Valenzuela et al., 1981; Lemischka et al., 1981; Cowan et al., 1983). 
Ultrastructural data suggest that microtubules are assembled from αβ dimers. Infact, it 
has been ascertained that tubulin dimers are heterodimers of αβ, rather than a mixture 
of αα and ββ dimers (Luduena et al., 1975).
In fact, hybrid microtubules may be formed in vitro by copolymerization of α and β 
tubulins from different species (Snyder and Mclntosh, 1976). Inspite of the similarity 
among tubulins from a wide variety of species, functional variation, have been observed 
in species to species. Thus clear immunological differences have been detected among 
different classes of tubulins such as outer doublets, central pair and mitotic apparatus 
(Mohri, 1976; Fulton et al., 1971). Tubulins from different species also differ in several 
properties like colchicine binding (Haber et al., 1972; Hart and Sabins, 1976; Davidse 
and Flach, 1977), in vitro assembly (Farrell, 1976; Langford, 1978; Murphy and 
Hiebsch, 1979) and immunological behaviour (Piperano and Luck, 1977; Morgan et al., 
1978). Recently we have isolated (manuscript in preparation) microtubule protein from 
higher plant Vigna radiata (mung bean) by streptomycin sulphate and ammonium 
sulphate fractionation followed by the in vitro polymerization of microtubule protein 
by Zn (II) (Banerjee et al., 1982). SDS-PAGE analysis has revealed that both of the 
subunits of plant tubulin are different from that of brain (figure 1). Attempts to assay 
colchicine binding with plant tubulins using radioactive colchicine (Weisenberg et al., 
 
 
 
Figure 1. Purification of plant tubulin. Experimental details are as in (Sen, 1984). (A), Crude 
cytoplasmic supernatant; (B), ammonium sulphate fractionated protein; (C), purified goat 
brain tubulin; (D), purified plant tubulin; (Ε) same as in C.
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1968) and by fluorometric method (Bhattacharyya and Wolff, 1974a) have not yet been 
successful in this laboratory.
 
Microheterogeneity and multiplicity of tubulins 
 
Multiple bands of either α or β tubulin are obtained after gel electrophoresis in certain
systems. This has been interpreted as due to microheterogeneity in tubulin (Bibring 
et al., 1976; Kobayashi and Mohri, 1977). On SDS gels, α occasionally splits into two 
bands apparently differing in charge but not in size (Bibring et al., 1976; Berkowitz et al., 
1977; Bibring and Baxandall, 1977a,b). The splitting is observed in tubulin from sea 
urchin mitotic spindles and in ciliary, but not flagellar outer doublets, implying a 
functional significance to the putative microheterogeneity (Bibring et al., 1976). 
Purified tubulin preparations from both Ehrlich ascites tumour cells and pig brain have 
been found to contain a third component migrating in between the α and β tubulins in 
SDS-PAGE (Lu and Elzinga, 1977). This has been subsequently characterized as a 
second form of β tubulin, by limited proteolysis and peptide mapping (Doenges et al., 
1979). Physarum tubulin contains a subunit protein which is similar to brain β tubulin. 
However, the faster moving band on SDS gel electrophoresis in this case appearing to 
be altogether a different protein, after peptide mapping analysis turns out to be very 
similar to brain α tubulin (Clayton and Gull, 1982). This raises the question on the 
typical nomenclature of tubulin subunits, according to electrophoretic mobility pattern 
i.e., fast moving constitutes the β subunit and the slow moving one is the α subunit. 
There is substantial evidence, based on colchicine binding, which suggests that
tubulin from lower eukaryotes may differ from that of higher organisms. In fact, the 
lower affinity of the tubulin from lower organisms and others for colchicine has been 
shown for Tetrahymena (Maekawa, 1978), Aspergillus (Davidse and Flach, 1977), 
Physarum (Roobol et al., 1980) and higher plants (Sen, 1984). Brain cells display 
extensive tubulin microheterogeneity which has been found to be developmentally 
determined, increasing from seven isotubulins at birth to nine distinct components 
during early postnatal brain maturation (Little, 1979). These types of results can be 
obtained from the phosphorylation of the subunits which alter the charge on the 
molecule. This actually appears to be the case in axonemal tubulin from 
Chlamydomonas, where α splits into five components on SDS gels and β into two, some 
of these bands differing in their degree of phosphorylation (Piperano and Luck, 1976). 
These arguments could also explain the splitting of α on hydroxyapatite chromato- 
graphy and the splitting in both α and β on isoelectric focussing (Kobayashi and Mohri, 
1977; Lu and Elzinga, 1977; Feit et al., 1977a,b; Witman et al., 1972). However, 
multiplicity of bands on electrophoresis does not necessarily imply multiplicity of 
amino acid sequence. 
Moreover, recently genetic analysis from different laboratories reveal that for both α 
and β tubulin there is more than one gene. Thus, Lopata et al. (1983) have reported four 
unique β tubulin genes in chicken. Mischke and Pardue (1983) showed the presence of a 
multigene family for α in Drosophila. Besides these a testis specific β tubulin is expressed 
in Drosophila (Kemphues et al., 1980, 1982; Raff and Kemphues, 1983). Thus though 
analysis of the data in the protein level does not signify totally the presence of 
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microheterogeneity, the genetic analysis reveal that there is some microheterogeneity in 
both α and β tubulin. Tubulin heterogeneity in the Trypanosome, Crithidia fasciculata 
has been adequately established (Russel et al., 1984). The interphase cell of C. 
fasciculata has three discrete and separable tubulin populations: the subcellular 
microtubule, the axonemal microtubule and the nonpolymerised cytoplasmic pool of 
tubulin. 
 
Microtubule associated proteins 
 
Tubulin purified by assembly disassembly procedure, contains some accessory proteins 
which copurifiy with tubulin through repeated cycles of assembly and disassembly. 
Two classes of accessory proteins have been reported. The first one is a set of two high 
Mr proteins having Mr around 300,000, were termed HMW by Borisy and coworkers 
(Borisy et al., 1975; Murphy and Borisy, 1975) and MAP by Rosenbaum and coworkers 
(Dentler et al., 1975). Another class of low Mr accessory proteins (Mr 55,000–70,000) 
has been reported by Kirschner and coworkers and were termed as τ proteins 
(Weingarten et al., 1975). The contents of accessory proteins in a preparation depends 
on the conditions used in the in vitro assembly. All these microtubule associated 
proteins are often collectively termed MAPs. MAPs could be separated from tubulin 
and are believed to be involved in the assembly of microtubules (Snyder and McIntosh,
1976). The role of MAPs in microtubule assembly has been discussed (Scheele and 
Borisy, 1979). Some of the enzyme activities have been observed to be associated with 
isolated microtubules: adenosine triphosphatase (Gelfand et al., 1978), guanosine 
triphosphatase (David-Pfeuty et al., 1977), protein kinase (Eipper, 1974), phos- 
phoprotein phosphatase (Jameson et al., 1980) nucleoside diphosphokinase (Jacobs 
and Huitorel, 1979), adenylate cylase (Margolis and Wilson, 1979), 3',5'-cyclic AMP 
phosphodiesterase (Watanabe et al., 1976), glutamate dehydrogenase (Karr et al., 1979), 
tyrosine hydroxylase (Borisy et al., 1975), alkaline phosphatase (Prus and Wallin, 1983) 
and DNA polymerase (Avila, 1980).
 
Interaction of tubulins with drugs
 
Several antitumour drugs, viz., colchicine and its analogues podophyllotoxin and vinca 
alkaloids inhibit mitosis and other cellular functions by speicifically binding to tubulin 
and inhibiting its assembly into microtubule. Consequently, these drugs have become 
valuable tools in understanding the role of microtubules in diverse cellular functions. 
 
 
Colchicine and its structural analogues 
 
Colchicine is one of the oldest drugs in the pharmacopoeia and has been named after 
the meadow saffron Colchicum autumnale (Eigsti and Dustin, 1955). It is a tropolone 
derivative with three rings – one trimethoxybenzene ring (A-ring), one saturated seven 
membered carbon ring (B-ring) with a substituted acetamido group and a tropolone 
ring (C-ring) with one oxo and one methoxy group (figure 2) (Margulis, 1975).
 The binding of colchicine with tubulin is one of the primary characteristics of the 
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Figure 2. Chemical structures of the tubulin binding drugs.
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protein and colchicine binding has been studied with tubulin prepared from many 
organisms and the higher plants (Flanagan and Warr, 1977; Hart and Sabins, 1973; 
Luduena et al., 1976; Miller, 1973; Stephens, 1977; Wilson and Friedkin, 1967; Wilson 
and Meza, 1973). Since, the binding reaction is highly specific and the colchicine- 
tubulin complex is very stable, [3H]-colchicine can be used as an assay for quantitative 
analysis of the binding reaction. To measure colchicine binding, various methods have 
been used which include gel filtration, filtration through DEAE cellulose filters, 
adsorption by charcoal (Borisy, 1972; Rappaport et al., 1975; Wilson and Bryan, 1974). 
Bhattacharyya and Wolff (1974a) have developed another unique method based on the 
promotion of fluoroscence upon binding of colchicine to tubulin. This method does not 
require the separation of the free ligand, since unbound colchicine does not have any 
fluorescence. This method thus permits the measurement of kinetic and thermo- 
dynamic parameters under equilibrium conditions.
The tubulin dimer has one binding site for colchicine (Weisenberg et al., 1968; 
Shelansky and Taylor, 1967; Wilson et al., 1974). The dissociation constants, Kd, in 
animal tubulins are in the range of 3·0–9·1 × 10–7 Μ when measured by equilibrium 
method (Barnes et al., 1977; Borisy and Taylor, 1967b; McClure and Paulson, 1977; 
Owellen et al., 1974; Sherline et al., 1975); when measured by kinetic methods, however, 
the dissociation constant is an order of magnitude lower (McClure and Paulson, 1977; 
Sherline et al., 1975; Bhattacharyya and Wolff, 1976b; Garland and Teller, 1975). The 
interaction between colchicine and tubulin is noncovalent and the drug is not altered 
chemically upon binding (Wilson and Friedkin, 1967; Borisy and Taylor, 1967a). The 
binding reaction is slow (Wilson and Bryan, 1974; Bhattacharyya and Wolff, 1974b) 
and almost irreversible in nature. Garland (1978) proposed a two step mechanism for 
the interaction of colchicine with tubulin: after a fast pre-equilibration step, a slow 
conformational change in the tubulin molecule leads to the formation of the fluorescent 
complex. Engelborghs’s group (Lambeir and Engelborghs, 1981) by using a fluores- 
cence stopped flow technique, arrived at the same conclusion as made by Garland. 
Ventilla et al., (1972) on the basis of the circular dichroic studies, have also 
demonstrated that colchicine binding leads to a conformational change of tubulin 
molecule. 
The colchicine binding site on tubulin is subject to decay whose properties have been 
intensively studied. The decay is an all or none phenomenon; the binding site simply 
disappears with first order kinetics, without a gradual change in affinity. The half life of 
decay of mammalian tubulin is about 5–7 h (McClure and Paulson,1977; Sherline et al., 
1975; Solomon et al., 1973), but solubilized sea urchin outer doublet tubulin decays with 
a half time of 5·2–5·6 h (Wilson and Meza, 1973). This decay is stabilized by salt, 
vinblastine, GTP, glycerol, sucrose, and dithiothreitol and by colchicine itself(Wilson 
and Meza, 1973; McClure and Paulson, 1977; Sherline et al., 1975; Solomon et al., 1973). 
The decay rate is linearly influenced by temperature and pH, being most stable at 0°C
and pH 6·75 (Wilson, 1970). 
Fluorescence studies using various analogues and derivatives of colchicine have 
revealed that atleast two moieties on the colchicine molecule are involved in the binding 
to tubulin (Bhattacharyya and Wolff, 1974a). One is the Α-ring in which insertion of a 
bulky group causes complete loss of binding. The other moiety is the tropolone ring or 
C-ring (figure 2). It has been suggested that C-ring in combination with Α-ring might be 
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responsible for the promotion of fluorescence. Replacement of tropolone ring by a 
phenyl ring in colchicine causes complete loss of binding (Zweig and Chignell, 1973). 
Correct positioning of the carbonyl moiety in C-ring appears to be necessary also. 
Modification in the C-ring (as in lumicolchicine) also leads to the complete loss of 
binding (Wilson, 1970). On the other hand, colchicine analogues modified at the B-ring 
moiety are known to have potent antimitotic activity which apparently rules out any 
major role of this moiety in the binding of colchicine to tubulin (Fitzgerald, 1976). But it 
has been shown from this laboratory that a minor change in the B-ring substituent may 
significantly affect the mechanism as well as the nature of binding. Thus, colcemid binds 
to tubulin fairly rapidly and reversibly, unlike colchicine (Banerjee and Bhattacharyya, 
1979). Recently, we have shown (Ray et al., 1984) that tubulin has two distinct colcemid 
binding sites. One site has a very high affinity while the other has low affinity. The 
affinity constants are respectively 1·3 × 10–5 Μ–1 and 0·7 × 10–5 Μ–1. The activation 
energy of the colcemid binding to tubulin has been found to be 9·8 Kcal/mol, a value 
lower than that for colchicine (19·5 Kcal/mol) (Ghosh Choudhury, 1984). 
Recently, from circular dichroism (CD) studies, Detrich et al. (1981) have shown 
that when colchicine binds to tubulin, the 340 nm CD band vanishes, from which they 
concluded that a conformational change in the colchicine molecule is taking place. 
Moreover, the binding of colchicine to tubulin induces a change from conformation 1 
to conformation 2 which provides a potential explanation for the enhancement of 
colchicine fluorescence (Bhattacharyya and Wolff, 1974a; Detrich et al., 1981). 
However, it has been recently reported from this laboratory (Ghosh Choudhury et al., 
1983a,b) that the two colchicine analogues desacetamidocolchicine and 2-methoxy-5- 
(2',3',4'-trimethoxyphenyl) tropone (figure 2) can bind to tubulin with a stoichiometry 
of one. The affinity constants for both of these drugs are 1·6 × 106 M–1 and 0·58 
× 106 M–1 respectively. The activation energies for binding of these drugs to tubulin 
have been determined (Ghosh Choudhury, 1984). The values are 6·4 Kcal/mol for both 
desacetamidocolchicine and 2-methoxy-5-(2',3',4'-trimethoxyphenyl) tropone respect- 
ively. From Dreiding model building and energy calculation it has been found in this 
laboratory (Ghosh Choudhury, 1984) that for binding and promotion of fluorescence, 
both of these analogues also require a conformational change like that of colchicine. 
Thus the activation energies for binding of these drugs to tubulin decrease in the order: 
 
Colchicine > Colcemid > Desacetamidocolchicine > 
2-methoxy-5-(2',3',4'-trimethoxyphenyl) tropone. 
 
Moreover, 2-methoxy-5-(2',3',4'-trimethoxyphenyl) tropone can bind tubulin even at 
4°C (Ray et al., 1981; Ghosh Choudhury, 1984). This indicates that atleast for this drug, 
tubulin does not require the so called time and temperature dependent conforma- 
tional change (Lambeir and Engelborghs, 1981) like that needed in the case of 
colchicine. In the case of desacetamidocolchicine the case is nearly similar to that of 2- 
methoxy-5-(2',3',4'-trmiethoxyphenyl) tropone (activation energy = 6·4 Kcal/mol). So 
from the existing literature and from a systematic and rigorous study in our laboratory 
the colchicine binding reaction may be postulated as:
 
Colchicine (1)  Colchicine (2) +T 
T-colchicine (2) → T-colchicine* (2)
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Colcemid(1)  Colcemid (2)+ T  
T-colcemid (2)(?) T-colcemid (2) 
 
Desacetamidocolchicine (1)  Desacetamidocolchicine (2) + T → 
T-Desacetamidocolchicine* (2) 
 
2-methoxy-5-(2',3',4'–trimethoxyphenyl) tropone (1)  
2-methoxy-5-(2',3',4'-trimethoxyphenyl) tropone (2)+T
T-2-methoxy-5-(2',3',4'-trimethoxyphenyl) tropone*, 
 
where 1 and 2 are the conformation 1 and conformation 2 of the drugs and asterics 
represents the fluorescent species of drug-tubulin complex.
On the basis of the assumption that colchicine behaves as a bifunctional ligand 
during binding to tubulin, Andrew and Timasheff (1982) postulated a model in which 
they suggested that ring C of colchicine (figure 2) binds first and this binding would 
induce in the protein a conformational change bringing the A-ring domain to proper 
position to bind the ring. But the discrepancy in this model is that there is no room for 
B-ring or B-ring substituent (acetamido group). But recent studies from this laboratory 
(Ray et al., 1981; Ghosh Choudhury et al., 1983a,b; Ghosh Choudhury, 1984) have 
revealed that there is a vast difference in activation energy and rate of binding among 
colchicine and its B-ring analogues. This finding leads to a conclusion that not only A 
and C-ring, but B-ring of colchicine also plays a major role in its binding to tubulin and 
determines some of the characteristics of the tubulin-colchicine interaction.
However, it has not been established which of the subunits of tubulin carries the 
colchicine binding site. The report by Roussett and Wolff (1980a) had indicated that the 
dimeric state of tubulin was not necessary for colchicine binding and that the colchicine 
binding site is located on either the α or β subunit. It has been found that 
lactoperoxidase, an enzyme used in the iodination of proteins, binds tubulin and 
dissociates α and β monomers as α-tubulin-lactoperoxidase and β-tubulin- 
lactoperoxidase complexes (Rousset and Wolf, 1980b). They found that the colchicine 
binding activity of tubulin was virtually unaltered after complete dissociation of 
subunits. It is known that the yeast tubulin can not bind colchicine (Haber et al., 1972) 
and yeast tubulin has been reported to contain an altered β subunit (Clayton et al., 
1979). In this context it is note worthy that α and β tubulins from a protease deficient 
strain of Saccharomyces cerevisiae comigrate with brain α and β tubulins (Ghosh 
Choudhury and Β. Β. Biswas, unpublished observation). Colchicine resistant mutants 
from Chinese hamster ovary (CHO) cells have been found to possess an altered β 
subunit (Cabral et al., 1980). All these information collectively indicate the presence of 
the colchicine binding site on the β subunit.
Colchicine binds only to tubulin dimers but not to intact microtubules. It has been 
demonstrated that the colchicine binding site of tubulin gets burried within the 
microtubule (Sherline et al., 1975; Wilson and Meza, 1973; Wilson et al., 1974). The anti- 
microtubular action of colchicine, therefore, believed to be mediated through an 
inhibition of microtubule assembly rather than a direct interaction with the micro- 
tubules (Wilson, 1975; Margolis and Wilson, 1977) which exist in a dynamic 
equilibrium with the subunit protein tubulin (Inoue and Sato, 1967). Thus, in the 
presence of colchicine, soluble tubulin gets complexed with the drug and becomes 
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inactive for microtubule formation, which in turn shifts the equilibrium and leads to the 
disassembly of microtubules.
 
Podophyllotoxin 
 
The antimitotic drug podophyllotoxin (figure 2) is extracted from the root of the May 
apple Podophyllum peltatum (Kelly and Hartwell, 1954). In general the antimitotic 
activity of podophyllotoxin is qualitatively indistinguishable from that of colchicine 
(Pfeffer et al., 1976; Wilson et al., 1976; Cortese et al., 1977). Although colchicine and 
podophyllotoxin share the same binding site on tubulin perhaps because of common 
trimethoxy benzene moiety (A-ring; figure 2) the mechanism of binding of podophyllo- 
toxin appears to be somewhat different from that of colchicine as shown by Cortese 
et al. (1977). Thus, (i) podophyllotoxin binds very rapidly, about 10 times as fast as 
colchicine; (ii) podophyllotoxin binds readily at 0°C; (iii) podophyllotoxin binding is 
freely reversible (Wilson et al., 1974; Wilson, 1975; Cortese et al., 1977). The association 
rate constant for podophyllotoxin binding to rat brain tubulin has been found to be 3·8
× 106 M–1 h–1. The dissociation rate constant is 1·9 h–1.
 
Vinca alkaloids 
 
Vinblastine and vincristine (figure 2) are potent antimitotic drugs obtained from the 
plant (Catharanthus roseus) G. Don (Vinca rosea L.) and are used in the treatment of 
neoplastic diseases. Vinblastine binds to tubulin at sites distinct from colchicine and 
podophyllotoxin (Bryan, 1972). The vinblastine binding reaction is very different from 
that of colchicine; the binding is reversible, temperature independent and rapid 
(Wilson, 1975; Mandelbaum-Shavit et al., 1976; Οwellen et al., 1972; Wilson et al., 1975, 
1978). The binding reaction is not affected by GTP, colchicine or calcium, although 
colchicine and sucrose stabilise the decay of the site (Owellen et al., 1972; Wilson et al., 
1975; 1978; Bhattacharyya and Wolff, 1976a). The decay is first order with a half time of 
3·5 h and is unusual in that it affects the affinity as well as the number of sites available 
(Wilson et al., 1978; Bhattacharyya and Wolff, 1976a). Two high affinity vinblastine 
binding sites with about the same affinity have been reported (Lee et al., 1975; Wilson et 
al., 1975). In contrast Bhattacharyya and Wolff (1976a) found two binding sites, 
differing in affinity. The reported vinblastine dissociation constants for mammalian 
tubulin range from 1·25 × 10–7 Μ to 4·5 × 10–5 Μ (Owellen et al., 1972, 1974; Lee et 
al., 1975; Bhattacharyya and Wolff, 1975).
In addition to high affinity sites, there may be several low affinity binding sites for 
vinblastine, about 20–30 for chick brain tubulin (Wilson, 1975). Vinblastine induces 
tubulin to aggregate into a series of highly organized structures. Vinblastine (2 
× 10–5 M) causes tubulin to dimerize (Lee et al., 1975); at 1·0 × 10–4M vinblastine, 
larger structures are seen, including ring, spirals and double helical structure called a 
macrotubule, consisting of two spirals with a centre-to-centre spacing of 18-28 nm 
(Erickson, 1975; Fujiwara and Tilney, 1975; Maratz and Shelansky, 1970). In some 
preparations, closely packed arrays of macrotubules constitute a crystal, which can also 
be induced in some cells in vivo (Maratz and Shelansky, 1970; Bensch and Malawista, 
1969; Bensch et al., 1969; Bryan, 1971). 
Molecular biology of tubulin: Interaction with drugs                    441
 
Griseofulvin 
 
Griseofulvin (figure 2) is a widely used antifungal antibiotic isolated from Penicillium 
griseofulvum. It arrests mitosis and causes disorientation of microtubules in vivo and 
can prevent microtubule assembly in vitro (Grisham et al., 1973a; Gull and Trinci, 1974). 
The Ki of griseofulvin for preventing assembly of recycled bovine brain microtubules is 
5·0–6·7 × 10–6 Μ (Wilson et al., 1975). There are contradictions about the specific 
binding of this drug to tubulin. It has been reported that [3H]-griseofulvin does not 
bind to pure tubulin (Grisham et al., 1973b). On the other hand Roobol et al. (1977) 
have shown that griseofulvin binds to a fraction containing MAPs.
 
Taxol 
 
Recently, it has been suggested that the antimitotic drug taxol (figure 2) an alkaloid 
from the plant Taxus brevifolia acts by a somewhat different mechanism. In contrast to 
other drugs mentioned, taxol acts as a promoter of microtubule assembly in vitro and 
renders microtubules resistant to depolymerization by cold (4°C) and Ca2+ in vitro and 
tissue culture cells (Schiff et al., 1979; Schiff and Horwitz, 1980). Taxol specifically 
inhibits cell separation in Trypanosoma cruzi. However, this taxol treatment permits 
continued multiplication of cellular organelles, including the nucleus, kinetoplast and 
flagellum. This observation suggests the presence of atleast two classes of microtubules 
in Trypanosoma cruzi as determined by taxol sensititivity (Baum et al., 1981). Tritium 
labelled taxol binds directly to microtubules in vitro with a stoichiometry approaching 
one (Parness and Horwitz, 1981). [3H]-Taxol binds to the macrophage like cell line, 
J 774·2 in a specific and saturable manner. Scatchard analysis of the species binding 
data demonstrates a single set of higher affinity binding sites (Manfredi et al., 1982). 
Using ultra-violet mutagen treated CHO cells, Cabral et al. (1981) selected taxol 
resistant cells. By two dimensional gel electrophoresis and peptide mapping these 
authors reported that the taxol resistant cells contain an altered α tubulin. This 
indicates that the taxol binding site may be on the α tubulin. From a study in this 
laboratory, some of the characteristics of the taxol induced purified tubulin polymeriz- 
ation in vitro have been elucidated (Ghosh Choudhury et al., 1983b; Ghosh Choudhury, 
1984). The antimitotic drug colchicine inhibits taxol induced purified tubulin 
polymerization in vitro with a Ki of 1·5 × 10–6 M. Moreover, like normal microtubules, 
colchicine binding site is burried in taxol induced polymers. Unlike normal assembly, 
however, taxol induced assembly is not inhibited by the colchicine analogues like 
desacetamidocolchicine and 2-methoxy-5-(2',3',4'-trimethoxyphenyl) tropone. Rather 
this analogue tubulin complex can copolymerize in the presence of taxol into 
microtubules. Moreover, from a rigorous thermodynamic analysis it has been shown 
that like normal MAPs induced microtubule assembly, taxol induced purified tubulin 
polymerization is also an entropically driven process (Johnson and Borisy, 1979; 
Ghosh Choudhury et al., 1983b; Ghosh Choudhury, 1984).
 
Other antimicrotubular drugs 
 
Benzimidazole derivatives which were first introduced as fungicides, are another group 
of important microtubule poisons. These include methyl benzimidazole-2-yl carbamate 
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(MBC) (figure 2), mebendazole, and oncodazole or nocodazole (Davidse and Flach, 
1977). These drugs exhibit antimitotic action similar to colchicine. A unique feature of 
MBC is that it selectively destroys the microtubules of parasitic worms (Borgers et al., 
1975) without any effect on those of the host. Moreover, it does not affect the in vitro 
assembly of porcine brain tubulin (Davidse and Flach, 1978). Nocodazole shows potent 
antimitotic activity in mammalian system and also inhibits the in vitro microtubule 
assembly (DeBrabander et al., 1976). It competes with colchicine for the binding site on 
tubulin. It is noteworthy to mention that nocodazole has got similarity with colchicine 
only with its B-ring moiety and both of them induce a change in the conformation of 
tubulin molecule after binding (Lee et al., 1980).
Another important antimicrotubular agent is steganacin (figure 2) which has been 
extracted from the wood and stems of Steganotaenia araliaces Hochst. It blocks Hela 
cell replication in mitosis. This drug is a competitive inhibitor of colchicine binding to 
tubulin and inhibits microtubule assembly in vitro (Schiff et al., 1978; Schiff and 
Horwitz, 1981). 
A potent antileukemic macrolide maytansine (figure 2), isolated from Maytenus 
ovatus, inhibits mitosis and also the in vitro assembly of microtubules (Remillard et al., 
1975). It competes with vinblastine and vincristine for their high affinity binding site on 
tubulin but does not lead to the formation of tubulin crystals (Bhattacharyya and 
Wolff, 1977). 
Rotenone (figure 2) is another potent antimitotic drug which interacts reversibly 
with the colchicine binding site on tubulin and inhibits in vitro assembly of 
microtubules (Brinkley et al., 1974; Marshall and Himes, 1978). Besides these, recently 
two compounds TN-16 (Arai, 1983) and antileprosy drug dopasone (Rajagopalon and 
Gurnani, 1983) have been reported to bind tubulin and inhibit microtubule assembly. 
Coumarin and isopropyl-(N-3 chlorophenyl) carbamate (CIPC) have been found to 
affect the mitotic division in lower eukaryotes suggesting that these have antimitotic 
activity (Katz et al., 1982). Coumarin has effects similar to those produced by 
antimicrotubule agents such as colchicine, CIPC and benzimidazole derivatives 
(Welker, 1982). Coumarin apparently does not affect spindle microtubules. This 
different specificity for cytoplasmic and spindle microtubules might be used to probe
the microtubule functions and its heterogeneity.
In the case of plants the herbicides, amiprophos-methyl (APM) have been found to 
poison specifically microtubule dynamics (Morejohn and Fosket 1984). The potent 
antimicrotubule action of APM has already been used to investigate the regulation of 
tubulin synthesis in Chlamydomonas (Collis and Weeks, 1978). Characteristic features 
of some important antimitotic drugs have been presented in table 1.
 
Mechanism of substoichiometric drug poisoning of microtubule assembly
 
Antimicrotubular drugs like colchicine, vinblastine and podophyllotoxin inhibit 
microtublue assembly both in vivo and in vitro in a substoichiometric manner, i.e. 
concentrations of drugs needed to inhibit the assembly is far substoichiometric to the 
free tubulin concentration in solution (Olmsted and Borisy, 1973; Wilson et al., 1976). 
The drug-tubulin complex rather than the drug itself, has been found to be the 
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Table 1. Some kinetic and thermodynamic parameters of drug tubulin interaction. 
 
 
 
 
 
 
 
 
 
a,b Indicate competitive binding site for colchicine and vinblastine respectively. N.D., Not determined.
 
 
 
inhibitory species (Margolis and Wilson, 1977). In vitro assembly is inhibited half 
maximally when only 2 % of the unpolymerized tubulin is complexed with the drug. 
 
The mechanism by which colchicine exhibits substoichiometric poisoning, has been 
studied by several workers in recent years. Margolis and Wilson (1977) demonstrated 
that colchicine-tubulin dimer (CD) complex adds on to the growing end of the 
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microtubule and irreversibly caps that end so that further addition of dimers becomes 
impossible. Microtubule assembly would therefore be poisoned owing to a reduction in 
the number of the assembly competent ends. Alternatively, Sternlicht and Ringel (1979) 
demonstrated that CD complex decreases the affinity of a microtubule end for further 
dimer addition. In this case, the poisoning of assembly results owing to a decrease in the 
apparent rate of dimer addition of microtubules without any decrease in the number of
the assembly competent ends.
Lambeir and Engelborghs (1980) have reported that the binding of CD to 
microtubule ends is reversible and the affinity of tubulin and CD for microtubule ends 
is of the same order of magnitude. Farrell and Wilson (1980) have re-examined the 
poisoning mechanism and found that the binding of CD complex to microtubule end 
was not irreversible. In time, some free tubulin dimer addition occurs over the CD 
block, ultimately resulting in recovery from that block. The recovery depends on the 
molar frequency of the addition of free tubulin dimers to that of CD complex. At high 
tubulin/CD ratios (>250) the recovery is essentially complete and copolymer 
formation occurs without a reduction in the number of assembly competent ends. 
However, at a very low ratios (< 14), frequency of addition of free tubulin dimers to 
that of CD complex falls below a critical ratio, and under such condition the inhibition 
of assembly becomes almost complete and the number of assembly competent end is 
reduced to zero.
Deery and Weisenberg (1981) have suggested that it is the colchicine-tubulin 
oligomer complex that is the actual inhibitory species. According to their model, the 
elongation of microtubules requires the addition of tubulin oligomers to the end of the 
microtubule. The presence of a single colchicine molecule to the end subunit of a linear 
oligomer could lead to an inhibition of the interaction of oligomers with the 
microtubule end. The extent of inhibition may depend upon the fraction of tubulin 
subunits in an oligomer that contain colchicine. Colchicine containing subunits might 
also inhibit the lateral co-operative interactions between the subunits of adjacent 
oligomers. 
 
Tubulin mRNA during growth and development 
 
It has been observed that tubulin synthesis can be regulated in the presence of drugs. 
Drugs (colchicine and nocodazole) that depolymerize microtubule decreases and those 
(taxol and vinblastine) favouring polymerization increase the synthesis of tubulin 
mRNA (Cleveland et al., 1981). 
Initial experiments have shown that mRNA fractions separated from the total 
mRNA of chick embryo brain by sucrose density gradient centrifugation could be 
translated in vitro in rabbit reticulocyte cell-free lysates containing [35S]-methionine. 
Both actin and tubulin were detected in the product by electrophoresis (Gilmore- 
Herbert and Heywood, 1976). Recently, Kirschner and his associates have described the 
isolation of two mRNAs coding for α and β tubulins by fractionation of poly (A) 
containing RNA from embryonic chick brain, thus giving evidence for two tubulin 
genes (Cleveland et al., 1978). These two mRNAs are very similar in Mr (650,000) as 
judged by mobility on denaturing gels containing methylmercury. However, as 
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reported by Bryan et al. (1978), the separate mRNAs coding for the α and β subunits 
were resolved on native gels, α migrating faster than β, indicating that α mRNA had 
more secondary structure than that of β mRNA. It has also been shown by Cleveland et 
al. (1978) that tubulin is synthesized in both free and membrane-associated polysomes. 
Peptide mapping in all cases confirmed that the in vitro translation products are α and β 
tubulins, which can coassemble into microtubules with added carrier microtubule 
proteins. Similarly, evidence for the synthesis of tubulin on membrane bound and free 
ribosomes from rat brain has been shown. In our laboratory it has been observed that 
colchicine can bind with the polysomes isolated from rat brain. Tubulin messenger 
RNA thus enriched from polysomes was used for cDNA synthesis and cloning 
(Chakraborty et al., 1983; Sen et al., 1984). Tubulin has also been detected among the in 
vitro translation products of poly (A) containing RNA from Tetrahymena in cell free 
wheat germ and rabbit reticulocyte systems. Isoelectric focusing of the products reveals 
heterogeneity in both α and β tubulins (Portier et al., 1979). Similar heterogeneity has 
also been observed in rat brain tubulins synthesized in vivo or by in vitro translation of 
rat brain RNA in a wheat germ or rabbit reticulocyte cell-free system (Saborio et al., 
1978). 
Gozes et al. (1980) have reported that prenatal rat brain tubulin can be resolved by 
isoelectric focusing into five or six components, while in mature brain nine distinct 
forms of tubulin were evident. Also, tubulins isolated from various regions of the brain 
displayed a quantitative difference in their microheterogeneity. Obviously, the question 
arises whether such microheterogeneity results from post-translational modification or 
from mulitple species of mRNA. Gozes et al. (1980) have shown that mature brain 
mRNA translated in vitro results in the synthesis of five tubulin forms. The mRNA 
could be resolved into several species coding for these distinct tubulin forms. An age 
dependent enhancement in the relative translation of the mRNA coding for a particular 
tubulin species has also been observed, this being characteristic of mature brain and not 
apparent among the in vitro translation products of prenatal mRNA. These results 
clearly indicate that at least some of the variations in tubulin microheterogeneity may 
be controlled at the mRNA level. 
Although the flagellar tubulin of Naegleria has been shown to be similar to tubulins 
isolated from other sources, it is interesting to note that antibodies prepared against the 
outer doublet tubulin react only with the flagellar tubulin and not even with the tubulin 
of the amoeboid form (Kowit and Fulton, 1974). Using this specific antibody, Lai et al. 
(1979) have demonstrated that during differentiation of an amoebae to a flagellate, the 
flagellar tubulin was the predominant product of translation in a wheat germ cell free 
system as directed by the poly (A) containing RNA extracted from these differentiating 
cells. However, no flagellar tubulin or tubulin message could be detected by the 
translation assay or using β tubulin clone probe (Fulton and Lai, 1982) 
against RNA extracted from amoebae prior to differentiation. These facts indicate that 
flagellar tubulin mRNA appears only during differentiation. However, it is not settled 
whether such appearance of translatable mRNA arises from de novo synthesis of 
mRNA or from post transcriptional processing of a preexisting mRNA species to a 
translatable form. 
A similar marked increase in the amount of translatable tubulin mRNA has also been 
observed during the regeneration of flagella by gametes of Chlamydomonas reinhardii 
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(Weeks and Collis, 1976). Of course, a major difference between the Chlamydomonas 
and Naegleria systems is that while the gametes of the former species contain 
preexisting flagella and sufficient tubulin for about 50% flagellation by length in the 
absence of protein synthesis (Weeks and Collis, 1976; Lafebvre et al., 1978), in the latter 
system no flagella preexist in the amoebae nor does any flagellation occur in the absence 
of prior protein synthesis. However, in both systems, flagellation during regeneration 
or differentiation is accompanied by an increase in translatable tubulin mRNA within 
15–20 min after the stimulus, reaching a maximum amount at about 1 h and then 
declining as regeneration or differentiation is completed (Lai et al., 1979). Using cDNA 
probe for hybridization with RNA, it was observed that tubulin sequences in RNA 
increased within 8 min following deflagellation of Chlamydomonas reinhardii, reached 
maximal levels by 50 min and then began to decrease by 80 min after deflagellation. 
One hybridization band was detected with use of the β tubulin probe, but two RNA size 
classes hybridised to the α tubulin probe (Silflow and Rosenbaum, 1981). From their 
study, it appears that tubulin synthesis after deflagellation is regulated essentially at 
transcriptional level.
Gene expression and mRNA of tubulin have been studied in ciliated protozoa 
Tetrahymena pyriformims (Fliss and Suyama, 1979; Zimmerman et al., 1983). The 
electrophoretic mobility of α tubulin subunit on SDS-PAGE differs but β tubulin 
subunits have the same mobility. In vitro synthesized tubulin was found to have exactly 
the same mobility as well. The pattern of fluctuation of tubulin mRNA was studied by 
in vitro translation and by hybridization with tubulin probe during cell cycle. This 
suggests that as the cell progresses through the cell cycle, tubulin synthesis is controlled 
at the mRNA level. 
Tubulin gene expression has been extensively studied in Drosophila melanogaster. 
During embyronic development, in Drosophila β3 tubulin subunit (β tubulin varient) is 
expressed transiently with concomitant increase of α tubulin in order to keep α and β 
tubulin ratio constant (Raff et al., 1982). A testis specific β tubulin has also been 
identified which is used in constructing the motile sperm tail (Kemphues et al., 1979). 
However, the products of this testis specific gene are not restricted to a single functional 
class. A family of four α tubulin genes have been isolated having difference in nucleotide 
sequence and atleast three of them have different patterns of transcription during 
Drosophila development. In addition, atleast two of the genes have more than one RNA 
product. The concentrations of the different RNA products from a single gene also 
vary independently during the development of the organism (Kalfayan and Wensink, 
1981). 
Hybridization of cloned cDNA probes of sea urchin, Layterhimus pictus to filter 
blots of RNA from developmental stages show that tubulin synthesis is regulated at 
translational level as well as by the variations in the accumulation of different tubulin 
transcripts. The α sequences in the egg reside primarily in RNAs that are larger (2·8 and 
2·5 kb) than the mature forms of the mRNA (1·75–2·2 kb); these are converted to the 
smaller forms after fertilization. In contrast, β mRNAs (1·8-2·2 kb) do not undergo any 
obvious size reduction after fertilization (Alexandraki and Ruderman, 1981). Some 
authors demonstrated the existence of atleast three different β tubulin mRNA and also 
developmental regulation of different α and β tubulin sequences.
Autoregulatory mechanism of control of expression of α and β tubulin has been shown 
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by Ben Ze’ev et al. (1979) and Cleveland et al. (1981) (Cleveland and Havercroft, 1983; 
Cleveland and Kirschner, 1982). Ben Ze’ev et al. (1979) demonstrated that colchicine, 
which depolymerizes microtubules and raises the level of tubulin, causes a cessation of 
tubulin synthesis by inhibiting the formation of new tubulin mRNA of cultured 
fibroblast cells. Similar conclusion was drawn by Cleveland and co-workers using 
immunoprecipitation and chicken α and β tubulins cDNA probe to monitor the cellular 
response of several cell types to a wide range of antitubulin drugs. Thus, it has been 
postulated that in virtually all higher eukaryotic cells there is an autoregulatory 
mechanism which apparently acts to maintain a specific level of depolymerized tubulin 
subunits and responds rapidly to lower an elevated level of unpolymerized subunits and 
the effect is possibly at the level of transcription process. However, the synthesis of 
tubulin proteins in chicken fibroblasts does not respond to microtubule depolymeriz- 
ing drugs in the same manner as cell lines from mammalian species, though the mRNA 
half life appears to be short (Cleveland et al., 1981). Recently Cleveland and Havercroft 
(1983) have demonstrated that the rates of tubulin mRNA synthesis were essentially 
unchanged in isolated nuclei from CHO cells whether the cells were treated with 
colchicine or not. Thus, autoregulatory control of tubulin mRNA is not mediated 
through the regulation of transcription process per se. Alternatively this apparent 
regulation of tubulin mRNA by depolymerized tubulin might be due to inhibition of 
proper tubulin mRNA processing and/or transport from the nucleus. In this 
connection an interesting observation may be mentioned where it has been shown that 
nuclear matrix, nuclear envelope and cytoplasmic skeletal elements appear to be 
involved in maturation, transport and decay of mRNAs in general (Muller et al., 1983). 
An interaction between the microtubules and the nuclear pore complex including the 
nucleoside triphosphatase might play a crucial role in the apparent autoregulatory 
control of tubulin mRNA synthesis.
In addition to regulation in response to unpolymerized tubulin levels, tubulin genes 
are differentially expressed during development. In Drosophila melanogaster there are 
four α tubulin genes, all located at different sites on the third chromosome (Kalfayan
and Wensink, 1981). Each gene yields characteristic mRNA levels at different stages of 
development as judged by RNA blot analyses using 3'-subcloned probes (Kalfayan and 
Wenskin, 1982). Atleast two human β tubulin genes each specifying a distinct isotype, 
are expressed in Hela cells, and the 2·6 kb mRNA band appears to be a composite of 
atleast two comigrating β tubulin mRNAs (Hall et al., 1983).
 
Cloning and organization of tubulin genes 
 
Tubulin gene from a variety of species has been cloned and sequenced (Cleveland, 1983) 
in a very short span of time. The first report of tubulin cDNA cloning starting from 
partially purified chick brain mRNA came from the laboratory of Kirschner (Cleveland 
et al., 1980). The authors adopted the most widely used strategy for cDNA cloning. Tubu- 
lin mRNA which was purified by sucrose density gradient centrifugation and confirmed 
by its in vitro translated product, was transcribed by reverse transcriptase and then by 
DNA polymerase I. After Sl nuclease treatment, the double stranded cDNA was tailed 
at the 3'-end with cytosine residue using terminal polydeoxynucleotidyl transferase. 
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The sizing of cDNA (1000 to 2500 base pairs) was monitored and these species were 
annealed to plasmid pBR 322 that was linearized at the pst-1 restriction site and tailed 
with guanosine residues. Transformation of Escherichia coli with this recombinant 
DNA containing putative α and β tubulin gene was performed according to the method 
of Goodman and MacDonald (1979). Selection of colonies was done by the colony 
hybridization technique (Grunstein and Hogness, 1975) using nick translated double 
stranded cDNA derived from enriched mRNA for tubulin. Hybrid plasmids containing 
cDNA sequences complementary to either α or β tubulin were further identified by 
hybrid selected translation and identities of both α and β tubulin clones have been 
confirmed by DNA sequencing. A similar approach was also used to prepare cDNA 
clone of α and β tubulin genes in Chlamydomonas (Silflow and Rosenbaum, 1981). 
Drosophila α tubulin clones were isolated by screening genomic DNA library using nick 
translated double stranded cDNA derived from purified mRNA specific for Drosophila 
tubulin (Kalfayan and Wensink, 1981). Tubulin genes have been cloned from human, 
rat, sea urchins, Trypanosomes, Leishmania and yeast using chicken brain cDNA as 
probe to screen either genomic library or cDNA library of respective species under 
appropriate stringent condition of hybridization to select colonies for α or β tubulin 
(Cowan et al., 1981; Lemischka et al., 1981; Grinzburg, et al., 1981; Alexandraki and 
Ruderman, 1981; Thomashow et al., 1983; Landfear et al., 1983; Neff et al., 1983). 
Recently, the tubulin sequence complexities and their corresponding genomic organis- 
ation have been studied in a variety of species (Cleveland 1983).
Chlamydomonas gene organisation and expression have been studied by two 
groups of workers using cloned α and β tubulin genes (Silflow and Rosenbaum, 1981; 
Brunke et al., 1982a,b) who demonstrated the existence of atleast two α tubulin and 
two β tubulin genes in this organism. Hybridization experiments further suggest that 
during tubulin induction four tubulin mRNA of discrete sizes are produced (two α 
and two β tubulin specific mRNA). Chlamydomonas cells contain several types of 
microtubules, including those found in the flagella, basal body, mitotic apparatus and 
cytoskeleton. Eventually it should be possible to determine whether all tubulin genes 
are expressed in this organism and to determine the type of microtubule(s) in which 
each gene product is found.
Alexandraki and Ruderman (1981) have analysed the multiplicity, heterogeneity and 
organization of the genes encoding the α and β tubulins in the sea urchin, Lytechinus 
pictus by using cloned cDNA and genomic tubulin sequences. Hybrid selection 
performed at different stringency demonstrated the presence of several heterogeneous, 
closely related tubulin mRNA, suggesting the existence of heterogeneous α and β 
tubulin genes. Hybridization analysis indicated that there are atleast 9 to 13 sequences 
for each of the two tubulin gene families per haploid genome, α Tubulin genes and β 
tubulin genes are not found to be linked but in contrast, some genes within the same 
family are separated or dispersed. Exact number of functional genes of α and β tubulin 
could not be ascertained out of a large number of tubulin genes estimated but the 
existence of atleast three different α tubulin mRNAs which have considerable 
divergence in the 3'-nontranslated regions, could be demonstrated.
Recently, cDNA and genomic clones containing α and β tubulins have been 
constructed from Trypanosome brucei (Thomashow et al., 1983; Seeback et al., 1983). 
Both groups of workers established that in contrast with the dispersed organization of 
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tubulin genes in other organism, Trypanosome α and β tubulin genes are physically 
linked and clustered in tandem repeats of approximately 13–17 copies per haploid 
genome of alternating α and β tubulin sequences. This arrangement may facilitate 
coordinate expression of the α and β tubulin subunits in species where cycles of 
polymerization and depolymerization are major features of the cell cycle. The 
arrangement of developmentally regulated α and β tubulin genes has been studied in the 
parasitic protozoan, Leishmania enriettii by using southern blot hybridization analysis 
(Landfear et al., 1983). The α tubulin genes occur in a tandem repeat whose monomeric 
unit may be represented by a 2-kilobase pst-1 fragment. Similarly, the β tubulin genes 
probably occur in a separate tandem repeat consisting of approximately 4-kilobase 
units unlinked to the tubulin repeats. In contrast to multiple α or β tubulin genes found 
in all the organisms so far analysed, the lower eukaryote Saccharomyces cerevisiae, 
having simple nonmotile life cycle has only one α and one β tubulin each in a haploid 
genome (Neff et al., 1983). Presence of an unique tubulin gene in the yeast genome was 
shown by complementation of a benomyl resistant conditional-lethal mutation which 
carries mutation at the gene(s) specifying β tubulin with a cloned DNA fragment from 
yeast homologous to a chicken β tubulin cDNA and which has an essential function in 
yeast. In Aspergillus nidulans, structural gene for β tubulin was found to be situated at 
benomyl binding site and benomyl resistant mutants sometimes exhibit an altered β- 
tubulin protein (Sheir-Neiss et al., 1978) and suppressor mutation of revertant of 
temperature sensitive ben A (benmyl resistant) mutant strain has been identified to be a 
structural gene mutation for α tubulin in Aspergillus nidulans (Morris et al., 1979). In 
rats and humans there are about 15 copies, well dispersed, each of α and β tubulin 
sequences (Lemischka and Sharp, 1982; Cleveland et al., 1980) and in chicken 4–5 copies 
each of these sequences (Cleveland et al., 1980; Lopata, et al., 1983), have been reported. 
Further, analysis of an expressed human β tubulin gene shows four coding regions of 
57, 109, 113 and 1053 bp. The size of these exons is also similar to those in a second 
expressed human β tubulin gene (Cowan et al., 1981; Lee et al., 1983). This similarity in 
exon structure also extends to the exons of four expressed β tubulin genes of chicken 
(Lopata et al., 1983). The size of the intervening sequences however, is highly variable. 
This suggests that sequences in exons in tubulin genes are well conserved while those in 
introns are not. 
The tubulin gene system particularly Chlamydomonas reinhardii shows rapid and 
coordinate induction of mRNA synthesis. Sequence analyses of those clustered genes 
reveal a short consensus sequence of 16 bp: [GCTC(G/C) AAGGC(G/T)(G/C) 
–(C/A)(C/A)G] just upstream of TATA box (Brunke et al., 1984). In general, the
putative regulatory elements within a particular gene set including developmentally
and homonally controlled genes (Cochet et al., 1982) and tubulin gene are similar but 
not identical (9–24 bp) and are present more than once in the upstream of TATA box. A 
summary of the sequence complexities of tubulin and the genomic organization in a 
variety of species is given in table 2. It is abundantly clear that the tubulin genes are 
present in large numbers in certain species and no significant correlation as a function 
of evolution could be established. The tubulin genes of most species thus examined 
constitute dispersed multigene families (Cleveland, 1983). The analysis of tubulin 
multigene family in different cases has shown that many of these sequences are 
pseudogenes (Lee et al., 1983; Lemischka and Sharp, 1982).
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Table  2.  Summary of tubulin gene sequences in various species. 
 
 
 
 
 
 
 
Tubulin pseudogenes and evolutionary significance 
 
As has been mentioned earlier, the human tubulin gene family contains a number of 
pseudogenes thereby increasing the multiplicity of genes. In the case of the human β 
tubulin family, of the ten genomic sequences analyzed (Wilde et al., 1982; Hall et al., 
1983; Lee et al., 1983), seven are pseudogenes and the remaining three sequences 
represent functional genes. These pseudogenes contain multiple deletions and/or in 
frame translation termination codons within the exon sequences. Two of these seven 
are traditional pseudogenes that contain intervening sequences. The other five are of 
novel type to the extent that (i) each sequence lacks intervening sequences, 
(ii) downstream from the AAT AAA consensus signal for poly (A) addition each carries 
a long coded tract of A residues and (iii) the entire sequence is flanked by a short direct 
repeat of 10–15 base pairs. It seems, therefore, that this type of pseudogenes orginates 
by a reverse transcription event in which a mature mRNA is copied into DNA. That the 
pseudogenes are, however, discovered for a number of other genes beside tubulin gene 
suggests that this is a common feature in eukaryotic cell. Pseudogenes have also been 
described in the rat α (Lemischka and Sharp, 1982) and human α tubulin gene (Lee et al., 
1983). It is predicted that multigene families whose expression occur in the germline 
cells of higher vertibrates are likely to contain members of the processed type. In that 
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ease similarities between the functional and processed pseudo human β tubulin gene are 
moderate, but an exclusive homology between 3'-untranslated regions is discern- 
ible (Hall et al., 1983). Thus extensive homology between 3'-untranslated regions 
implies a close evolutionary relationship. In pseudogenes, mutations are found to be 
random since these are not subjct to selective pressure. The functional gene, however, 
can acquire the changes that are silent (i.e. no amino acid change). Therefore, changes in 
the third codon position represent the cumulative effects of evolutionary drift in both 
functional and pseudogenes. Assuming that about half of the third base differences are 
due to changes in human β tubulin pseudogene and a rate of divergence of 0·7 % per 106 
years for neutral mutations (Perler et al., 1980), this pseudogene may be estimated to 
have originated approximately 4·4 × 106 years ago (Hall et al., 1983). It is apparent that 
these integrated transcripts (pseudogenes) retain many of their original features for 
millions of years and might be recruited, in whole or in part, for the generation of new 
functional sequences. 
 
Conclusion 
 
Microtubules are present in most eukaryotic cells where they fulfill diverge functions 
very vital to the existence of the cell. Until recently, tubulin research has been restricted 
exclusively to protein isolated from mammalian brain tissue. It is becoming increas- 
ingly apparent that, despite its conserved nature, tubulin exists as a family of proteins. 
As the range of organisms from which tubulin has been isolated broadens, the extent of 
diversification of the protein becomes clearer. Eukaryotic microorganisms are found to 
be particularly useful in revealing the heterogeneity of tubulins. It is interesting to study 
as to how the cells control differential assembly and dissociation of microtubules 
with the existence of different isotypes of tubulin subunits. The question also 
arises how to identify functionally different microtubules at specific stage of cell 
cycle and cell growth? In fact, different isotypes of tublulins have been identified in 
cytoplasmic pool, in flagella and in the pellicle of certain eukaryotic microorganisms. It 
will definitely be interesting if heterogeneity of tubulins from the spindle apparatus can 
be established.
That multiple tubulin genes are expressed differentially as a function of differenti- 
ation is now established. Whether each polypeptide produced is truly functionally 
distinct remains to be answered. Autoregulatory mechanisms of control of expression of 
α and ß tubulins have been well documented by the experimental results that colchicine, 
which depolymerizes microtubules and raises the level of free tubulin causes inhibition 
of tubulin synthesis by lowering tubulin mRNA production. However, this auto- 
regulatory control of tubulin mRNA seems not to be mediated through the regulation 
of transcription process per se, instead, tubulin mRNA processing and/or transport 
from the nucleus might be the cause for this regulation. The question arises as to how 
tubulin exerts its effects on the processing and/or transport of tubulin mRNA. 
Considering that nuclear matrix, nuclear envelope and cytoskeletal elements might be 
involved in maturation, transport and decay of mRNAs in general, it would be 
interesting to find out any interaction of these components on the autoregulatory 
control of tubulin mRNA synthesis.
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For what reason do the cells synthesize new tubulin for the flagella during 
differentiation inspite of the presence of abundant amount of tubulin? What leads to 
the expression of flagellar tubulin genes and what causes the disappearance of flagellar 
tubulin mRNA as the differentiation is completed? How, utilization of flagellar tubulin 
is related to its synthesis? These are the questions yet to be resolved.
Several antitumour drugs such as colchicine and its analogues, podophyllotoxin and 
vinca alkaloids inhibit mitosis and other cellular functions by specifically binding to 
tubulin and inhibiting its assembly into microtubule. The number of other chemical 
compounds which bind specifically with the tubulin particularly from eukaryotic 
microorganisms and plants has ever been increasing. However, data on the physico- 
chemical characteristics of the binding of these compounds except colchicine with 
tubulin are still limiting to propose any unifying concept for their binding with tubulin. 
It might turn out to be interesting to use these chemical compounds to delineate the 
different classes of microtubules and/or different populations of tubulins within a 
single microtubule.
The tubulin genes except the yeast gene are organized in multigene families. These 
are either tandemly arranged, clustered or well dispersed. The multigene family 
encoding tubulin proteins is of particular interest because, whereas numerous lines of 
evidence point to conservation of tubulin proteins, different species possess a broad 
range of tubulin like sequences. Although the coding regions of tubulin genes are 
rigidly conserved, the untranslated regions including the introns are not. Interestingly, 
the analysis of tubulin multigene families in different species has shown that many of 
these sequences are pseudogenes. Information on the sequences of these pseudogenes, 
both α and β, suggest that most of these were derived via an mRNA intermediate. The 
accumulation of genetic lesions and the occurrence of oligo A tracts in intronless 
pseudogenes indicate that they are functionless and therefore not subject to selective 
pressure. The question then arises how these pseudogenes are retained? Since the 
pseudogenes retain many of the features of expressed genes it is possible that the 
generation of new functional sequences might arise out of them. In any case, the precise 
relationship between genetic complexity and microtubule function has not yet been 
elucidated. 
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